A new study in Psychological Science details a phenomenon in which graphic and detailed warnings by the Food and Drug Administration may eventually boost sales for potentially dangerous drugs, such as Zoloft. Some patients over the long-term said they were more likely to buy drugs like Zoloft after hearing side effects warnings, because it increases their trust in the company — unaware the warnings are required by the FDA.
Zoloft, a selective serotonin reuptake inhibitor (SSRI), is among the most-prescribed antidepressants in the U.S. Several studies have linked Zoloft to severe side effects, including birth defects among women who use the drug while pregnant.
Zoloft birth defects include omphalocele, anencephaly, brain defects, heart defects, persistent pulmonary hypertension of the newborn and other congenital birth defects. The drug’s manufacturer Pfizer faces multiple Zoloft birth defects lawsuits alleging that the drug caused severe birth defects.